VisionPoint Advisory Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$576K Sell
2,609
-7
-0.3% -$1.94K 0.09% 234
2026
Q1
$773K Buy
2,616
+163
+7% +$48.4K 0.15% 162
2025
Q4
$670K Buy
2,453
+100
+4% +$27.2K 0.13% 175
2025
Q3
$636K Sell
2,353
-127
-5% -$34.6K 0.13% 170
2025
Q2
$684K Buy
2,480
+855
+53% +$233K 0.15% 151
2025
Q1
$431K Buy
1,625
+91
+6% +$22.4K 0.15% 125
2024
Q4
$357K Buy
+1,534
New +$353K 0.12% 133
2024
Q3
Sell
-42
Closed -$8.26K 339
2024
Q2
$8.26K Buy
+42
New +$8.68K ﹤0.01% 511
2023
Q4
Sell
-49
Closed -$9.81K 772
2023
Q3
$9.81K Buy
+49
New +$9.74K ﹤0.01% 445

Other funds holding CME

VisionPoint Advisory Group's CME Position: Q2 2026 in Review

VisionPoint Advisory Group reduced its CME Group (CME) stake by 0.27% in Q2 2026, selling an estimated $1.94K and leaving 2,609 shares worth $576K. The position accounts for 0.09% of the portfolio, ranked #234.

VisionPoint Advisory Group first reported a position in CME in Q3 2023 and has held it in 9 quarters since. The position peaked at $773K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • VisionPoint Advisory Group held 2,609 shares of CME Group worth $576K as of Q2 2026.
  • VisionPoint Advisory Group sold 7 CME Group shares in Q2 2026, an estimated $1.94K.
  • CME Group made up 0.09% of VisionPoint Advisory Group's portfolio in Q2 2026, its #234 holding.
  • VisionPoint Advisory Group first reported a position in CME Group in Q3 2023 and has held it in 9 quarters since.
  • VisionPoint Advisory Group's CME Group position peaked at $773K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.